Patent ID: 8512746
Filing Date: 2013-08-20
Classification: A61K,A61P

Abstract:
1. The extended release pharmaceutical composition of levetiracetam or pharmaceutically acceptable salts thereof in the form of a core tablet including a rate controlling matrix, wherein said rate controlling matrix consists of glyceryl behenate, a polymethacrylate polymer, lactose and hydroxypropyl methylcellulose and in which the amount of levetiracetam is 1 to 95% by weight of the total composition, the amount of glyceryl behenate is 1 to 60% by weight of total composition, the amount of polymethacrylate polymer is 0.5 to 20% by weight of total composition, the amount of hydroxypropyl methylcellulose is 0.1 to 5% by weight of total composition and in which less than 30 percent of levetiracetam is released within about the first 2 hours to prevent dose dumping.